Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for a range of medical conditions.
Next stop is 5k
ノート
During the upcoming year the company plans to complete the development work of neural human implants including QC methods and full QC release of the implants and implants raw materials: hydrogel and induced Pluripotent Stem Cells (iPSCs).